1
|
Zhang C, Li P, Yu L, Li L. Burden of cataracts in developing countries: a trend analysis based on data from China, 1990 to 2021. Front Med (Lausanne) 2025; 12:1550788. [PMID: 40365490 PMCID: PMC12069301 DOI: 10.3389/fmed.2025.1550788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2025] [Accepted: 04/08/2025] [Indexed: 05/15/2025] Open
Abstract
Objective To investigate the trends in cataract-related blindness and vision impairment burden among cataract patients in China, the largest developing country, from 1990 to 2021, providing evidence to inform future cataract prevention and control strategies in developing countries. Patients and methods This study utilized data from the Global Burden of Disease (GBD) 2021 database to assess the prevalence, age-standardized prevalence rates (ASPR), and years lived with disability (YLDs) associated with cataract-related blindness and visual impairment in China and other regions from 1990 to 2021. Joinpoint regression, decomposition analysis, and ARIMA modeling were employed to analyze trends and predict future disease burden. Results From 1990 to 2021, the number and crude rate for cataract related blindness and visual impairment increasing significantly in China. The age-standardizes rate increased from 878.30 to 989.58 per 100,000 population for cataract prevalence, and from 73.40 to 61.39 per 100,000 population for cataract YLDs. The majority of number of prevalence and YLDs are concentrated in the 65-89 age range. Women had higher cataract prevalence and YLDs than men. Population aging is the primary driver of the growing burden of cataract, contributing 73.12% and 98.3% to the increases in prevalence and YLDs, respectively. By 2035, the crude prevalence rate and crude YLDs rate of cataracts are projected to increase by 26.06% and 23.03%, respectively, compared to 2021. The age-standardized prevalence and YLDs rate attribute to cataract in China were lower than global averages and ranked third among neighboring countries. Conclusion Despite advancements in cataract treatment that have alleviated some of the disease burden, population growth and aging continue to drive the increasing prevalence of cataract-related vision impairment in China. Addressing gender disparities and improving access to cataract surgery and preventive care are crucial for reducing this growing burden.
Collapse
Affiliation(s)
- Cancan Zhang
- Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China
| | - Pingping Li
- Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China
| | - Lurun Yu
- Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China
| | - Lu Li
- Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China
| |
Collapse
|
2
|
Huang KZY, Trope GE, Buys YM, Jin YP. Unequal access to routine eye exams in Canada: an analysis of government-funded eye exam coverage policy and associated vision health outcomes. CANADIAN JOURNAL OF OPHTHALMOLOGY 2025; 60:e297-e299. [PMID: 39681311 DOI: 10.1016/j.jcjo.2024.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Revised: 10/15/2024] [Accepted: 11/24/2024] [Indexed: 12/18/2024]
Affiliation(s)
- Kiko Zi Yi Huang
- Institute of Medical Science, University of Toronto, Toronto, ON, Canada
| | - Graham E Trope
- Institute of Medical Science, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada
| | | | - Ya-Ping Jin
- Institute of Medical Science, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
| |
Collapse
|
3
|
Samuels I, Hamm LM, Silva JC, Tousignant B, Furtado JM, Goodman L, Watene R, Adams J, Ramke J, Harwood M. Use of the CONSIDER statement by eye health researchers when conducting and reporting research involving Indigenous peoples: an online survey. Eye (Lond) 2024; 38:2187-2194. [PMID: 38195924 PMCID: PMC11269661 DOI: 10.1038/s41433-023-02881-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 11/28/2023] [Accepted: 11/29/2023] [Indexed: 01/11/2024] Open
Abstract
BACKGROUND Indigenous peoples experience worse eye health compared to non-Indigenous peoples. Service providers and researchers must avoid perpetuating this inequity. To help achieve this, researchers can use the CONSolIDated critERia for strengthening the reporting of health research involving Indigenous peoples (CONSIDER) statement. This study aimed to identify the degree to which the CONSIDER statement has been used by eye health researchers when conducting and reporting research with an Indigenous component, and how they perceive its relevance in their future research. METHODS We used purposive sampling to recruit eye health researchers from any country who have undertaken research with an Indigenous component. The online survey collected quantitative and qualitative data and was analysed using descriptive statistics and reflexive thematic analysis. Responses were gathered on a four-point Likert scale (1 to 4), with four being the most positive statement. RESULTS Thirty-nine eye health researchers from nine countries completed the survey (Aotearoa New Zealand, Argentina, Australia, Brazil, Canada, Colombia, Guatemala, Panama, Peru); almost two-thirds (n = 24) undertake epidemiological research. On average, participants disclosed only 'sometimes' previously reporting CONSIDER items (2.26 ± 1.14), but they thought the items were relevant to eye health research and were motivated to use these guidelines in their future research. Some participants requested clarity about how CONSIDER aligned with existing guidelines, and when and how to apply the statement. Others shared rich experiences of the benefits to their research of Indigenous leadership and collaboration. CONCLUSIONS The CONSIDER statement is perceived as a valuable tool by these eye health researchers, and there are opportunities to maximise uptake and use, including increasing awareness of the statement, clarity about when it applies, and availability of institutional-level support.
Collapse
Affiliation(s)
- Isaac Samuels
- Department of Ophthalmology, University of Auckland, Auckland, 1142, New Zealand
| | - Lisa M Hamm
- School of Optometry and Vision Science, University of Auckland, Auckland, 1142, New Zealand
| | | | - Benoit Tousignant
- School of Optometry, Université de Montréal, Montreal, H3T 1P1, QC, Canada
- Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, H3C 3T4, QC, Canada
| | - João M Furtado
- Division of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, 14049900, Brazil
| | - Lucy Goodman
- School of Optometry and Vision Science, University of Auckland, Auckland, 1142, New Zealand
| | - Renata Watene
- School of Optometry and Vision Science, University of Auckland, Auckland, 1142, New Zealand
| | - Jaki Adams
- The Fred Hollows Foundation, Darwin, Australia
| | - Jacqueline Ramke
- School of Optometry and Vision Science, University of Auckland, Auckland, 1142, New Zealand.
- International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
| | - Matire Harwood
- School of Population Health, University of Auckland, Auckland, 1142, New Zealand
| |
Collapse
|
4
|
Blais N, Tousignant B, Hanssens JM. Comprehensive Primary Eye Care: A Comparison Between an In-Person Eye Exam and a Tele-Eye Care Exam. CLINICAL OPTOMETRY 2024; 16:17-30. [PMID: 38197048 PMCID: PMC10775700 DOI: 10.2147/opto.s436659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 12/16/2023] [Indexed: 01/11/2024]
Abstract
Introduction Proper access to primary eye care is essential in addressing vision impairment, and tele-eye care examinations are a promising solution that could facilitate this access in many rural or remote areas. Even though remote eye exams are becoming increasingly frequent, comprehensive tele-eye care exams are still limited by the lack of published data. The aim of this study is to compare a comprehensive tele-eye care exam with a gold standard in-person primary eye care exam with an emphasis on refractive measurements, ocular health assessment, confidence level of the eye care providers and patient satisfaction. Methods Sixty-six participants underwent two comprehensive eye exams performed by two eye care providers. One was a gold standard in-person exam, while the other was a remote exam performed by an eye care provider through videoconference. An overall patient satisfaction survey and a questionnaire for visual comfort with a trial frame from each modality were completed and the eye care providers scored their confidence level for each test. Exam results and diagnoses were compared between both modalities. Results Tele-refraction has a good to excellent agreement with in-person subjective refraction in terms of sphero-cylindrical power and best corrected visual acuity. There was no statistically significant difference for visual comfort between both modalities. The agreement between in-person and remote exams for ocular health assessment ranged from fair to almost perfect, but there was a low prevalence of ocular pathologies within the study sample. The confidence level of the eye care providers and patient satisfaction were statistically higher in-person. Conclusion Tele-eye care appears to be statistically and clinically non-inferior to in-person eye exams, especially for refraction, but the low prevalence of ocular pathologies somewhat limits the comparison of its efficacy for ocular health assessment. More studies on comprehensive tele-eye care exams are needed.
Collapse
Affiliation(s)
- Nicolas Blais
- School of Optometry, Université de Montréal, Montréal, Québec, Canada
| | - Benoit Tousignant
- School of Optometry, Université de Montréal, Montréal, Québec, Canada
- Department of Social and Preventive Medicine School of Public Health, Université de Montréal, Montréal, Québec, Canada
| | | |
Collapse
|
5
|
Fang R, Yu YF, Li EJ, Lv NX, Liu ZC, Zhou HG, Song XD. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019. BMC Public Health 2022; 22:2068. [PMID: 36369026 PMCID: PMC9652134 DOI: 10.1186/s12889-022-14491-0] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2022] [Accepted: 10/31/2022] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND To evaluate the global burden of cataracts by year, age, region, gender, and socioeconomic status using disability-adjusted life years (DALYs) and prevalence from the Global Burden of Disease (GBD) study 2019. METHODS Global, regional, or national DALY numbers, crude DALY rates, and age-standardized DALY rates caused by cataracts, by year, age, and gender, were obtained from the Global Burden of Disease Study 2019. Socio-demographic Index (SDI) as a comprehensive indicator of the national or regional development status of GBD countries in 2019 was obtained from the GBD official website. Kruskal-Wallis test, linear regression, and Pearson correlation analysis were performed to explore the associations between the health burden with socioeconomic levels, Wilcoxon Signed-Rank Test was used to investigate the gender disparity. RESULTS From 1990 to 2019, global DALY numbers caused by cataracts rose by 91.2%, crude rates increased by 32.2%, while age-standardized rates fell by 11.0%. Globally, age-standardized prevalence and DALYs rates of cataracts peaked in 2017 and 2000, with the prevalence rate of 1283.53 [95% uncertainty interval (UI) 1134.46-1442.93] and DALYs rate of 94.52 (95% UI 67.09-127.24) per 100,000 population, respectively. The burden was expected to decrease to 1232.33 (95% UI 942.33-1522.33) and 91.52 (95% UI 87.11-95.94) by 2050. Southeast Asia had the highest blindness rate caused by cataracts in terms of age-standardized DALY rates (99.87, 95% UI: 67.18-144.25) in 2019. Gender disparity has existed since 1990, with the female being more heavily impacted. This pattern remained with aging among different stages of vision impairments and varied through GBD super regions. Gender difference (females minus males) of age-standardized DALYs (equation: Y = -53.2*X + 50.0, P < 0.001) and prevalence rates (equation: Y = - 492.8*X + 521.6, P < 0.001) was negatively correlated with SDI in linear regression. CONCLUSION The global health of cataracts is improving but the steady growth in crude DALY rates suggested that health progress does not mean fewer demands for cataracts. Globally, older age, females, and lower socioeconomic status are associated with higher cataract burden. The findings of this study highlight the importance to make gender-sensitive health policies to manage global vision loss caused by cataracts, especially in low SDI regions.
Collapse
Affiliation(s)
- Rui Fang
- Beijing Tongren Hospital, Beijing, 100730, China
- Capital Medical University, Beijing, 100730, China
| | - Yang-Fan Yu
- Beijing Tongren Hospital, Beijing, 100730, China
- Capital Medical University, Beijing, 100730, China
| | - En-Jie Li
- Beijing Tongren Hospital, Beijing, 100730, China
- Capital Medical University, Beijing, 100730, China
| | - Ning-Xin Lv
- Beijing Tongren Hospital, Beijing, 100730, China
- Capital Medical University, Beijing, 100730, China
| | - Zhao-Chuan Liu
- Beijing Tongren Hospital, Beijing, 100730, China
- Capital Medical University, Beijing, 100730, China
- Beijing Tongren Eye Center, Beijing, 100730, China
- Beijing Ophthalmology&Visual Sciences Key Lab, Beijing, 100730, China
| | - Hong-Gang Zhou
- The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Key Laboratory of Molecular Drug Research, Nan kai University, Tianjin, China.
| | - Xu-Dong Song
- Beijing Tongren Hospital, Beijing, 100730, China.
- Capital Medical University, Beijing, 100730, China.
- Beijing Tongren Eye Center, Beijing, 100730, China.
- Beijing Ophthalmology&Visual Sciences Key Lab, Beijing, 100730, China.
| |
Collapse
|
6
|
van Staden D. Guest editorial: A call for health advocacy to be included as an outcome competency into optometric education programmes. AFRICAN VISION AND EYE HEALTH 2021. [DOI: 10.4102/aveh.v80i1.708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
7
|
Nichani P, Trope GE, Buys YM, Markowitz SN, El-Defrawy S, Ngo G, Markowitz M, Jin YP. Frequency and source of prescription eyewear insurance coverage in Ontario: a repeated population-based cross-sectional study using survey data. CMAJ Open 2021; 9:E224-E232. [PMID: 33731423 PMCID: PMC8034370 DOI: 10.9778/cmajo.20200104] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Insurance coverage may reduce cost barriers to obtain vision correction. Our aim was to determine the frequency and source of prescription eyewear insurance to understand how Canadians finance optical correction. METHODS We conducted a repeated population-based cross-sectional study using 2003, 2005 and 2013-2014 Canadian Community Health Survey data from respondents aged 12 years or older from Ontario, Canada. In this group, the cost of prescription eyewear is not covered by the government unless one is registered with a social assistance program or belongs to a specific population. We determined the frequency and source of insurance coverage for prescription eyewear in proportions. We used survey weights provided by Statistics Canada in all analyses to account for sample selection, a complex survey, and adjustments for seasonal effect, poststratification, nonresponse and calibration. We compared unadjusted proportions and adjusted prevalence ratios (PRs) of having insurance. RESULTS Insurance covered all or part of the costs of prescription eyewear for 62% of Ontarians in all 3 survey years. Of those insured, 84.1%-86.0% had employer-sponsored coverage, 9.0%-10.3% had government-sponsored coverage, and 5.7%-6.8% had private plans. Employer-sponsored coverage remained constant for those in households with postsecondary graduation but decreased significantly for those in households with less than secondary school graduation, from 67.0% (95% confidence interval [CI] 63.2%-70.8%) (n = 175 000) in 2005 to 54.6% (95% CI 50.1%-59.2%) (n = 123 500) in 2013-2014. Government-sponsored coverage increased significantly for those in households with less than secondary school graduation, from 29.2% (95% CI 25.5%-32.9%) (n = 76 400) in 2005 to 41.7% (95% CI 37.2%-46.1%) (n = 93 900) in 2013-2014. In 2013-2014, Ontarians in households with less than secondary school graduation were less likely than those with secondary school graduation to report employer-sponsored coverage (adjusted PR 0.79, 95% CI 0.75-0.84) but were more likely to have government-sponsored coverage (adjusted PR 1.27, 95% CI 1.06-1.53). INTERPRETATION Sixty-two percent of Ontarians had prescription eyewear insurance in 2003, 2005 and 2013-2014; the largest source of insurance was employers, primarily covering those with higher education levels, whereas government-sponsored insurance increased significantly among those with lower education levels. Further research is needed to elucidate barriers to obtaining prescription eyewear and the degree to which affordability impairs access to vision correction.
Collapse
Affiliation(s)
- Prem Nichani
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Graham E Trope
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Yvonne M Buys
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Samuel N Markowitz
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Sherif El-Defrawy
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Gordon Ngo
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Michelle Markowitz
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont
| | - Ya-Ping Jin
- Faculty of Medicine (Nichani), Institute of Health Policy, Management and Evaluation (Nichani), Department of Ophthalmology and Vision Sciences (Trope, Buys, Markowitz, El-Defrawy, Jin) and Dalla Lana School of Public Health (Jin), University of Toronto; Toronto Western Hospital (Trope, Buys, Markowitz), University Health Network; Kensington Eye Institute (El-Defrawy), Toronto, Ont.; Faculty of Medicine (Ngo), University of Western Ontario, London, Ont.; private practice (Markowitz), Toronto, Ont.
| |
Collapse
|